We are live on ! Find out more

528 hedge funds and large institutions have $7.35B invested in Chemed in 2024 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 163 increasing their positions, 213 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more call options, than puts

Call options by funds: $14.3M | Put options by funds: $3.39M

11% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 57

0% more funds holding

Funds holding: 527528 (+1)

1.39% less ownership

Funds ownership: 94.07%92.67% (-1.4%)

13% less capital invested

Capital invested by funds: $8.46B → $7.35B (-$1.11B)

23% less repeat investments, than reductions

Existing positions increased: 163 | Existing positions reduced: 213

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

Holders
528
Holders Change
+1
Holders Change %
+0.19%
% of All Funds
6.95%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
63
Increased
163
Reduced
213
Closed
57
Calls
$14.3M
Puts
$3.39M
Net Calls
+$10.9M
Net Calls Change
+$10.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$884M +$1.45M +2,568 +0.2%
BlackRock
2
BlackRock
New York
$733M -$21.7M -38,493 -3%
Kayne Anderson Rudnick Investment Management
3
Kayne Anderson Rudnick Investment Management
California
$308M -$6.1M -10,820 -2%
Neuberger Berman Group
4
Neuberger Berman Group
New York
$266M +$3.27M +5,809 +1%
State Street
5
State Street
Massachusetts
$255M +$9.09M +16,121 +3%
William Blair Investment Management
6
William Blair Investment Management
Illinois
$251M -$6.91M -12,259 -3%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$181M +$2.8M +4,966 +1%
Impax Asset Management Group
8
Impax Asset Management Group
United Kingdom
$176M -$169K -300 -0.1%
Morgan Stanley
9
Morgan Stanley
New York
$163M -$63.4M -112,404 -27%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$150M +$25.5M +45,174 +19%
TD Asset Management
11
TD Asset Management
Ontario, Canada
$144M -$11.9M -21,039 -7%
JP Morgan Chase
12
JP Morgan Chase
New York
$141M +$11.4M +20,310 +8%
EIP
13
Epoch Investment Partners
New York
$134M +$6.86M +12,167 +5%
BTW
14
Boston Trust Walden
Massachusetts
$128M +$12.5M +22,105 +10%
Ameriprise
15
Ameriprise
Minnesota
$124M -$820K -1,454 -0.6%
Northern Trust
16
Northern Trust
Illinois
$110M +$19M +33,710 +19%
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$106M +$10.5M +18,584 +10%
Invesco
18
Invesco
Georgia
$96.5M +$3.92M +6,957 +4%
Norges Bank
19
Norges Bank
Norway
$95.9M +$2.54M +4,514 +3%
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$82M -$13.1M -23,197 -13%
DekaBank Deutsche Girozentrale
21
DekaBank Deutsche Girozentrale
Germany
$80.6M
CCM
22
Copeland Capital Management
Pennsylvania
$80.3M +$12.3M +21,834 +17%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$75.4M +$2.73M +4,838 +4%
Millennium Management
24
Millennium Management
New York
$74.6M +$49.2M +87,316 +163%
Charles Schwab
25
Charles Schwab
California
$72.1M +$7.55M +13,394 +11%

CHE Hedge Fund Activity: Q4 2024 in Review

528 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q4 2024, worth a combined $7.35B — down 13% from $8.46B a quarter earlier.

Buyers outnumbered sellers: 63 funds opened new CHE positions and 57 closed out — a net gain of 6 holders — while 163 added to existing stakes and 213 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $58.1M. The largest seller was TimesSquare Capital Management, cutting an estimated $90.7M.

  • 528 institutional investors held Chemed (CHE) as of Q4 2024, up from 527 in Q3 2024.
  • Funds reported $7.35B of Chemed stock for Q4 2024, down 13% quarter-over-quarter.
  • 63 funds opened new Chemed positions in Q4 2024 and 57 closed out, a net change of +6 holders.
  • The largest Chemed buyer in Q4 2024 was Point72 Asset Management, an estimated $58.1M added.
  • The largest Chemed seller in Q4 2024 was TimesSquare Capital Management, an estimated $90.7M sold.

Based on aggregated 13F filings for Q4 2024.